Ganetespib is under investigation for the treatment of BREAST CANCER, Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.